Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part B Competitive Acquisition Plan Needs Significant Changes, Attorney Says

Executive Summary

The Centers for Medicare & Medicaid Services' proposal for competitive acquisition of Part B-covered drugs requires "significant changes" to be effective, attorney Carolyn McElroy told an American Conference Institute/Pharmaceutical Care Management Association conference in Washington, D.C. April 18

You may also be interested in...



US Oncology Taking On Drug Distribution Role

Cancer services company US Oncology is building its own drug distribution capacity to serve medical practices in its oncology network

US Oncology Taking On Drug Distribution Role

Cancer services company US Oncology is building its own drug distribution capacity to serve medical practices in its oncology network

Medicare Rx Plans Likely To Focus On Managing Use Of Low-Cost Drugs

The catastrophic coverage provided under the Medicare Part D benefit may give private plan sponsors little incentive to control use of high-cost drugs, American Enterprise Institute Resident Fellow Scott Gottlieb said April 27

Related Content

Topics

UsernamePublicRestriction

Register

PS045719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel